NEW YORK, March 18 (GenomeWeb News) - Boehringer Ingelheim has obtained from MorphoSys the option to exclusively license several therapeutic antibodies being co-developed by the firms under a previous agreement with the two companies, the company said today.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.